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Proteomics profiling of interactome dynamics by
colocalisation analysis (COLA)†
Faraz K. Mardakheh,‡*a Heba Z. Sailem,‡ab Sandra Ku¨mper,a Christopher J. Tape,ac
Ryan R. McCully,a Angela Paul,a Sara Anjomani-Virmouni,a Claus Jørgensen,d
George Poulogiannis,a Christopher J. Marshall§a and Chris Bakal*a
Localisation and protein function are intimately linked in eukaryotes, as proteins are localised to specific
compartments where they come into proximity of other functionally relevant proteins. Significant
co-localisation of two proteins can therefore be indicative of their functional association. We here present
COLA, a proteomics based strategy coupled with a bioinformatics framework to detect protein–protein
co-localisations on a global scale. COLA reveals functional interactions by matching proteins with
significant similarity in their subcellular localisation signatures. The rapid nature of COLA allows mapping
of interactome dynamics across different conditions or treatments with high precision.
Introduction
Systems level understanding of biological processes requires
unravelling of functional interactions on a global scale. A func-
tional interaction is a molecular association between two or more
proteins which share a common, interdependent, biological
function. Mining of such interactions on a global scale is often
achieved by high-throughput genetic screens,1 where interactions
are inferred by commonality in phenotypic outcomes of genetic
gain or loss of function events.2,3 Alternatively, functional inter-
actions can be inferred from molecular interaction analyses, on
the principle of ‘guilt by association’.4 Determining such inter-
actions on a global scale, however, has remained a fundamental
technical challenge. Reporter based methods such as Yeast-2-
Hybrid (Y2H) or protein-fragment complementation assay (PCA)
are labour intensive, and can only reveal direct biochemical
interactions.5,6 Aﬃnity Purification coupled with Mass Spectro-
metry (AP-MS),7,8 or proximity based labelling,9 are similarly
labour intensive, but do reveal indirect interactions. A major
downside of both AP-MS and proximity based labelling methods,
however, is that the analysis time is directly proportional to the
number of proteins being investigated, rendering large scale
comparative interactome analysis across diﬀerent conditions
diﬃcult due to an increasing number of mass spectrometry runs.
Moreover, tagging of cellular proteins required for both methods
could aﬀect their activity, resulting in potential artefacts.
Recently, a novel proteomics based approach has been
utilised to reveal interactions by assessing the co-behaviour
of interacting proteins when biochemically fractionated.10
Havugimana et al. used three parallel chromatography methods
in conjugation with proteomics, separating soluble cellular com-
plexes based on charge, pKa, and density.
11 Kristensen et al., on
the other hand, used size-exclusion chromatography in conjuga-
tion with proteomics to separate complexes by size.12 Proteins
with similar elution profiles were then matched as likely con-
stituents of the same complexes. The key advantage of these
approaches is allowing simultaneous determination of bio-
chemical interactions from a fixed number of mass spectro-
metry runs.12,13 However, a downside of both approaches is
that they are limited to soluble proteins, and therefore are not
well suited for detecting insoluble complexes. Moreover, while
matching proteins based on biochemical co-fractionation can
reveal strong associations that survive such fractionations,
many physiologically relevant functional interactions only occur
transiently, thus are often missed during stringent biochemical
separations.9
Eukaryotic cells are highly compartmentalised assembly of
organelles, macro-molecular complexes, and spatially organised
subcellular functional regions. As a result, where a protein is
localised inside a eukaryotic cell can be indicative of its function.
More importantly, colocalisation of two or more proteins can be
indicative of their functional interaction.14 We hypothesised
that, similar to multi-variate phenotypic signatures used in
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high-throughput genetic interaction analyses,2 quantitative
multi-dimensional subcellular localisation signatures can be
used to match functionally interacting proteins on the basis of
their colocalisation. We here present COLA, a streamlined
proteomics–bioinformatics strategy to infer functional inter-
actions from significant similarities in subcellular localisation
patterns. COLA uses complete subcellular fractionation in
conjugation with quantitative proteomics to generate a quanti-
tative, multi-dimensional, subcellular localisation signature
for each identified cellular protein. Bootstrapped hierarchical
clustering is then used to match proteins with significant
similarity in their localisation signatures. Crucially, COLA is not
limited to soluble protein complexes, and can reveal functional
interactions on a global scale based on subcellular proximity
with high Precision and Sensitivity. Finally, by utilising Tandem-
Mass-Tagging for quantitative profiling of different subcellular
fractions, we developed a multiplexed version of COLA, named
iCOLA, that could be utilised to rapidly map interactomes across
different conditions and treatments, thereby revealing inter-
actome dynamics.
Experimental
Cell-lines, tissue culture, and reagents
A375P, A375M2, and unlabelled RPE cells were grown in DMEM
supplemented with 10% FBS. For SILAC labelling, RPE cells
were grown for at least 7 doublings in SILAC light (plus L-Arg &
L-Lys) or heavy (plus L-Arg10 & L-Lys8) DMEM supplemented with
L-Pro (600 mg L1) and 10% dialysed FBS. Rabbit polyclonal
antibody against FN1 (sc-9068) was from Santa Cruz. Rabbit
monoclonal or polyclonal antibodies against VASP (3132), H2AX
(7631), CDH2 (4061), PDI (3501), ERM (3142), and VIM (5174)
were from Cell Signalling Technology. Mouse monoclonal anti-
GAPDH antibody was from Novus Biologicals. Mouse polyclonal
antibody against DIS3 (ab-68570) was from Abcam. Mouse mono-
clonal anti beta-actin (A1978) and anti-EEA1 antibodies were
from SIGMA.
Cell lysis and subcellular fractionations (COLA)
Several types of subcellular fractionation procedures were tested
initially; of those four protocols were chosen as they were the
most reproducible while providing the most non-overlapping
information. These were serial solubilisation, serial centri-
fugation in combination with aqueous biphasic extraction,
transwell protrusion purification, and conditioned media
collection (secreted/extracellular fraction). As a whole cell lysate
control, an additional dish seeded in the same way was directly
lysed by 2% SDS, Tris-pH 7.6 lysis buﬀer which solubilises
all cellular proteins. For all fractionations, cells were seeded
(107 per dish) the day before and fractionated in parallel as
described below:
(1) Serial solubilisation. For serial solubilisation, Pierce
subcellular fractionation kit (78 840) was used with modifica-
tion. Briefly, cells were scraped oﬀ (1  15 cm dish) in cold PBS
and pelleted before being solubilised serially into 5 fractions
according to the kits’ protocol (cytosol, membrane, nuclear soluble,
nuclear chromatin, and cytoskeleton). A pellet remaining at the
end of the procedure was also solubilised by 2% SDS, Tris-pH 7.6,
which constituted a second cytoskeleton fraction.
(2) Serial centrifugation. For serial centrifugation, Abcam
plasma membrane extraction kit (ab65400) was used with modi-
fication. Briefly, cells were scraped oﬀ (2  15 cm dish) in cold
PBS and pelleted before being homogenised with a Dounce
homogenizer in the Homogenize Buﬀer Mix, according to the
kit’s protocol. Subsequently, the nuclear fraction (nucleus +
envelope) was pelleted by spinning the homogenate at 700  g
for 10 minutes (4 1C), and solubilised in 2% SDS, Tris-pH 7.6.
The supernatant was then further centrifuged at 10 000  g for
30 min (4 1C) to pellet the cellular membranes. The remaining
supernatant (cytosol + microsomes) was taken away, and the
pellet was resuspended in 200 ml of the ‘Upper Phase’ aqueous
biphasic extraction solution, according to the kit’s protocol. An
equal volume of ‘Lower Phase’ solution (200 ml) was then added
to the mix, vortexed thoroughly, and incubated on ice for
5 minutes, before being centrifuged at 1000  g for 5 minutes
to separate the two phases. In parallel, a fresh tube of mixed
upper and lower phase solutions without any sample was
similarly prepared and centrifuged to separate the two phase
solutions. The upper phase of the tube with samples was then
carefully taken away from the lower phase and put in a new
tube. The two phases were then extracted again by adding 100 ml
of the separated lower or upper phase solutions from the tube
without samples to each (lower to upper and vice versa) as before
(mixing thoroughly, incubating on ice for 5 minutes, before
centrifugation at 1000  g for 5 minutes). The second separated
upper phase from the initial upper phase (plasma membrane),
and the second separated lower phase from the initial lower
phase (intracellular membranes), were thenmoved to new tubes,
diluted in 5 volume of ice-cold water, and kept on ice for
5 minutes to precipitate the extracted proteins. The proteins
were then pelleted by centrifugation at 16 000g in a micro-
centrifuge for 10 minutes (4 1C). The supernatants were then
removed and discarded and the pellets (intracellular or plasma
membrane fractions) were solubilised in 2% SDS, Tris-pH 7.6.
Next, protein concentrations of the fractions were measured by
BCA assay (Pierce), and balanced.
(3) Protrusion purification. Cell protrusions were fractio-
nated using 3 mm pore polycarbonate transwell filters (corning
75 mmmembrane inserts) as described before.15 One transwell
per condition was used (107 cells per transwell), and cells
were allowed to form protrusions through the pores for 4 h.
Transwells were then washed in PBS, fixed with 20 1C methanol
for 20 minutes, washed again with PBS, and the protrusions from
the bottom of the filter were shaved oﬀ using a glass cover slip,
with the cover slip being dipped in 2% SDS, Tris-pH 7.6 lysis
buﬀer during shaving. The reciprocal SILAC control whole cell
lysates were generated by lysing the cells on the top of the filter
(cell-bodies) by direct addition of 2% SDS, Tris-pH 7.6 lysis buﬀer
to the top. Protein concentrations for both protrusions and the
cell-bodies were then measured by BCA assay (Pierce), followed
by balancing.
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(4) Conditioned media collection. For separation of the
extracellular fraction, 107 cells were seeded the day before on
a 15 cm dish (1 dish per condition). The next day, media was
changed to serum free, and cells were left to secrete proteins
overnight into the media, before collecting the media. This
conditioned media was subsequently spun at 16000g for 10 min
to clear any cell debris, followed by concentrating B20 fold
using Amicon ultra centrifugal filter units (10 kDa cut-oﬀ), and
solubilising the concentrated proteins in 2% SDS, Tris-pH 7.6.
As a whole cell lysate control, the remaining cells after removal
of the conditioned media were directly lysed by 2% SDS, Tris-pH
7.6. Again, protein concentrations for both extracellular fraction
and the whole cell lysates were measured by BCA assay (Pierce),
followed by balancing.
Mass spectrometry sample preparation and LC-MS analysis
(COLA)
Fraction–lysate mixes were trypsinised using the FASP proto-
col.16 Following digestion, peptides were purified by zip-tip C18
clean-up tips (Millipore), lyophilised using a speedvac, and the
dried peptides were then reconstituted in 1% acetonitrile/0.1%
formic acid for LC-MS/MS. LC-MS/MS runs were performed by
ICR’s proteomics core facility as described before,15 with minor
modifications. Briefly, reversed phase chromatography was
performed using an HP1200 platform (Agilent, Wokingham,
UK). One third of each sample was analysed as a 6 ml injection.
Peptides were resolved on a 75 mm I.D. 15 cm C18 packed
emitter column (3 mm particle size; Nikkyo Technos Co., Ltd,
Tokyo, Japan) over 240 min using a three-step gradient of
96 : 4 to 50 : 50 buffer A : B (t = 0 min 4% B, 0.5 min 4% B,
40.0 min 10% B, 170.0 min 25% B, 240.0 min 50% B) (buffer A:
1% acetonitrile/3% dimethyl sulfoxide/0.1% formic acid;
buffer B: 80% acetonitrile/3% dimethyl sulfoxide/0.1% formic
acid) at 250 nL min1. Peptides were ionised by electro-
spray ionisation using 1.8 kV applied immediately pre-
column via a microtee built into the nanospray source. Sample
was injected into an LTQ Velos Orbitrap mass spectrometer
(Thermo Fisher Scientific, Hemel Hempstead, UK) directly
from the end of the tapered tip silica column (6–8 mm exit
bore). The ion transfer tube was heated to 275 1C and the S-lens
set to 60%. MS/MS were acquired using data dependent
acquisition based on a full 30 000 resolution FT-MS scan with
preview mode disabled. The top 20 most intense ions were
fragmented by collision-induced dissociation and analysed
using normal ion trap scans. Precursor ions with unknown or
single charge states were excluded from selection. Automatic
gain control was set to 1 000 000 for FT-MS and 30 000 for
IT-MS/MS, full FT-MS maximum inject time was 500 ms and
normalised collision energy was set to 35% with an activation
time of 10 ms. Wideband activation was used to co-fragment
precursor ions undergoing neutral loss of up to 20 m/z from
the parent ion, including loss of water/ammonia. MS/MS was
acquired for selected precursor ions with a single repeat count
acquired after 8 s delay followed by dynamic exclusion with a
10 ppmmass window for 60 s based on a maximal exclusion list
of 500 entries.
Mass spectrometry sample preparation and LC-MS analysis
(iCOLA)
For iCOLA, 100 mg of each subcellular fraction (Fig. 3A) was
digested by FASP, amine-TMT-10-plex labelled (Pierce 90111)
on filter membranes (iFASP),17 eluted, pooled, and lyophilised.
Peptides were desalted using C18 solid-phase extraction (SPE).
LC-MS3 analysis of TMT labelled peptides was performed by
Cancer Research UK Manchester Institute’s proteomics core
facility. Briefly, reverse-phase chromatographic separation was
performed on an RSLCnano (Thermo Scientific) with a PepMap
RSLC C18 (2 mm bead size), 100 A, 75 mm I.D.  50 cm
EasySpray unit at 60 C using a 120 min linear gradient of
0–50% solvent B (MeCN 100% + 0.1% formic acid (FA)) against
solvent A (H2O 100% + 0.1% FA) with a flow rate of 300 nL min
1.
The separated samples were infused into an Orbitrap Fusion
mass spectrometer (Thermo Scientific). The mass spectrometer
was operated in the data-dependent mode to automatically
switch between Orbitrap MS and MS/MS acquisition. Survey full
scan MS spectra (from m/z 300–2000) were acquired in the
Orbitrap with a resolution of 120000 at m/z 400 and FT target
value of 1  106 ions. The 20 most abundant ions were selected
for MS2 fragmentation (isolation window 1.2m/z) using collision-
induced dissociation (CID), dynamically excluded for 30 seconds,
and scanned in the ion trap at 30000 atm/z 400. MS3multi-notch
isolated ions (10 notches)18 were fragmented using higher-energy
collisional dissociation (HCD) and scanned in the Orbitrap (from
m/z 100–500) at 60 000 at m/z 400. For accurate mass measure-
ment, the lock mass option was enabled using the polydimethyl-
cyclosiloxane ion (m/z 445.12003) as an internal calibrant. Four
serial technical replicate injections were performed per TMT
sample set to boost the identification coverage.
Proteomics search and quantifications
Mass-spectrometry search and SILAC/TMT quantifications were
performed by Maxquant.19 The search was performed against
the Human Uniprot database, with a false detection rate (FDR)
of 1% for both peptides and protein identifications, calculated
using reverse database search. Second-peptide search, match
between runs (using a 2 minutes matching window), and
re-quantify options were all enabled to achieve maximum quanti-
fication depth. Only razor or unique, unmodified peptides, as well
as methionine oxidized peptides were used for quantification.
To achieve higher coverage and better matching of SILAC
samples, all raw files were searched together. Following the
search, preliminary data analysis on the search results was
performed by Perseus software from the maxquant package.20
Briefly, reverse, contaminants, and proteins identified from
only modified peptides were filtered out. For iCOLA, all fraction
reporter ion channels were normalised to the total lysate
channel. Ratios were transformed to log 2 scale. For all further
downstream co-localisation analysis, data from each replicate
(reciprocally labelled SILAC replicates or multiple injection
TMT replicates) was averaged and z-scored, generating a single
value per protein per fraction for each experiment. Proteins were
filtered to have ratio values for all fractionations. 2D annotation
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enrichment analysis was performed by Perseus software as
described in ref. 21, using GO, GSEA, CORUM, Pfam, SMART,
KEGG, and Uniprot Keyword annotations. A Benjamini–Hochberg
false detection rate of 2%, and an enrichment cut off delta score
of +0.2 per category was applied. PCA analysis was also performed
by Perseus using the averaged z-scored values. Pearson correlation
analysis was also performed by Perseus prior to averaging.
Co-localisation identification
Interactions between proteins were defined as proteins that
their localisation patterns significantly and robustly cluster
together in diﬀerent bootstrapped samples. It was performed
using pvclust function in R with Euclidean distance, average
linkage, and AU (Approximately Unbiased) p-value measure22
(https://cran.r-project.org/web/packages/pvclust/). 500 (for iCOLA)
or 1000 bootstrappings were performed and only clusters with
p-value o0.05, 0.01, or 0.001 were considered. If a cluster
consisted of more than 2 proteins, then all possible pairwise
interactions were considered.
Interaction overlap analysis
Interactions that were identified using bootstrapped clustering
were evaluated by calculating the overlap with the following
protein–protein interaction reference databases:
(1) STRING-all interactions:23 all string interactions were
downloaded (Oct 2014). String gene IDs were mapped to corres-
ponding gene IDs using UNIPROT ID mapping tool. Interactions
with medium confidence (combined score 40.4) were consid-
ered where the score is based on neighbourhood, gene fusion,
co-occurrence, co-expression, experiments (physical interactions),
databases and text mining methods.
(2) STRING-physical interactions:23 interactions that have
experimental evidence in STRING.
(3) Pathway Commons:24 based on Pathway Commons 7
(May 2015) with exclusion of BioGrid as this database includes
the studies we used for benchmarking our methods against
(see below).
(4) CORUM25 (protein complex database): gene IDs were
mapped using UNIPROT.
The overlap was calculated as the percentage of identified
interactions in COLA or iCOLA that were also reported in the
above mentioned databases. The significance of the overlap was
calculated using right tail Fisher Exact Test (R) and hypergeometric
probability. For the number of interactions in the reference
databases, only interactions that include the proteins that were
quantified in our fractionation experiments were considered. We
benchmarked our method against Kristensen et al.,12 (7204 inter-
actions), and Rolland et al.,6 (13944 interactions). To calculate the
significance of overlap, the number of interactions in reference
database was modified to only include the proteins that were
identified using each of these methods.
Mitochondrial flux analysis
Mitochondrial flux analysis was performed as described before.26
Briefly, A375P and A375M2 cells were plated at 2  104 cells per
well of a XF Mito Stress Kit plate (Agilent) (n = 18) and oxygen
consumption was measured in real-time using a XFe 96 Analyzer
(Seahorse Biosciences) for 70 minutes. 1 mM oligomycin, 0.25 mM
FCCP, and 0.5 mM rotenone/antimycin (R/A) were serially added
at indicated time-points to assess basal mitochondrial, maximal
mitochondrial, and non-mitochondrial oxygen consumption rates,
respectively. Cell numbers were normalised using Cyquant Kit
(Thermo Fisher).
Interactome quality assessment
COLA and iCOLA (A375M2) derived binary interactions, as well
as interactions of Kristensen et al.,12 and Rolland et al.,6 were
evaluated against STRING, Pathway Commons, and CORUM
databases. To measure Sensitivity, the percentage of CORUM
interactions that were identified in each method, from the total
number of CORUM interactions for the observed proteins was
calculated. For measurement of False Positive Rate (FPR), we
employed two diﬀerent approaches. In the first approach, we
first generated a list of all hypothetical binary interactions (based
on identified proteins for each method). All known interactions
that were reported in STRING, Pathway Commons, and CORUM
were then filtered out. Next, we took 1000 random samples of
interactions from the remaining interactome. Sample size was
set to 200 interactions.27 FPR for each method was then calcu-
lated by finding the percentage of the 200 interactions that were
reported each time. The values were then averaged and reported.
In the second approach, we generated a list of all possible
hypothetical binary interactions based on the list of the identi-
fied proteins in each method that have a CORUM annotation.
All known binary interactions that were reported in STRING,
Pathway Commons, and CORUM were then filtered out. This list
was termed anti-CORUM. FPR was then calculated by finding the
percentage of anti-CORUM interactions that were reported by
each method. To estimate Precision, we used Sensitivity, and
anti-CORUM based FPR values to estimate the number of true
positives (S), false positives (V), true negatives (U), and false
negatives (T) for each method, as defined in (Table 3). Precision
was then calculated as S/(S + V).
Results
Analysis of functional interactions by COLA
To generate quantitative subcellular localisation signatures for
analysis of colocalisation, we first developed a multi-variate
method to assess subcellular localisation of proteins by proteo-
mics. We used Stable Isotope Labelling of Amino acids in Culture
(SILAC) in conjugation with extensive subcellular fractionation28
(Fig. 1A). SILAC experiments were carried out in duplicate with
label switching, and an average ratio was calculated for each
protein per each fraction, using whole cell lysate as standard
(Fig. 1A). Protein localisation signatures derived from combining
all fractions were then clustered using bootstrapped hierarchical
clustering to reveal similar signatures with high confidence
(Fig. 1A).
To maximise acquisition of novel, digitised, information on
subcellular protein distributions which would be suitable for
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Fig. 1 Proteomics-based profiling of colocalisation (COLA) to reveal functional associations. (A) Outline of methodology. SILAC heavy or light labelled
cells were subjected to subcellular fractionation then mixed with an equal amount of whole cell lysate from the opposite label for relative quantification.
SILAC mixes were digested and analysed by LC-MS/MS. Averaged normalised SILAC ratios for all fractions together create a multi-variate localisation
signature for each protein (GNAS was used as example). Signatures were then subjected to unsupervised hierarchical clustering with Euclidean average
linkage. Bootstrapping was used to reveal clustering matches with high confidence (in color) from the rest (blacked out). GNAS, GNB1, and GNB2 which
are known to constitute a complex are shown as example of a bootstrapped cluster. (B) Outline of the subcellular fractionations. Four independent
fractionations procedures were used: (1) serial solubilisation of cellular proteins (fractions 1 to 6), (2) serial centrifugation combined with aqueous biphasic
extraction which separates plasma membrane from internal membranes (fractions 7 to 10), (3) separation of actin-rich cellular protrusions using micro-
porous transwell filters (fraction 11), (4) separation of the extracellular/secreted proteins by collecting conditioned media (fraction 12). (C) Validation of
serial solubilisation method (fractions 1–6) by western blotting: PDI, ER membrane protein; DIS3, soluble nuclear protein; H2AX, nucleosome constituent;
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hierarchical clustering, we used four parallel independent
fractionation procedures with highly distinct individual fractions
(Fig. 1B). The majority of subcellular fractions came from two
main fractionation procedures, one based on serial solubilisation
by using successive solubilising buﬀers, and the other based on
serial centrifugation (Fig. 1B). Both of these procedures are fast,
reproducible, require little optimisation, and cover major sub-
cellular compartments. To further expand on subcellular infor-
mation, we also collected two additional independent fractions,
the actin-rich cellular protrusions, and the extracellular compart-
ment (Fig. 1B). Protrusions are purified using transwell based
physical separation of cell protrusions from the cell-body,15
and the extracellular compartment is collected by removing and
concentrating conditioned media (Fig. 1B). Overall, we identified
4950 proteins from human Retinal Pigment Epithelial (RPE) cells,
out of which 1886 had a full subcellular localisation profile with
no missing values (Dataset S1, ESI†). The quality of fractionations
was examined by western blotting for markers of specific frac-
tions (Fig. 1C–F), as well as category enrichment analysis using
the Gene Ontology Cellular Compartment (GOCC) database
(Table 1 and Dataset S2, ESI†). For assessing the reproducibility
of fractionations, we determined Pearson’s correlation coeffi-
cients across all fraction replicates. While correlation coefficient
within fraction replicates was on average 0.65, suggestive of
good reproducibility of fractionations, coefficients between
different fractions was only 0.1 on average (Fig. 1G and H),
indicating that fractions provide unique information towards
the localisation signatures. The distribution and variance of
different fractions were comparable (Fig. 1I), and importantly,
no single fraction contributed disproportionately to the overall
variance (Fig. 1J), ruling out potential bias towards a specific
compartment in later downstream analysis. The correlation
between the overall subcellular localisation signatures, across
two independent biological replicates was calculated to be
0.70 (Fig. 1K).
To detect proteins that have significantly similar localisation
signatures, and therefore are expected to functionally interact,
we used hierarchical clustering (Fig. 1A). Hierarchical clustering
is ideal for multi-variate assessment of functional interactions as
it matches proteins into discrete functional units.3 However,
a common shortcoming of standard hierarchical clustering is
sensitivity to samples order and variation in clustering results
depending on sample inclusion.22 To ensure the significance
and robustness of our clustering to permutations, we performed
bootstrapped clustering to reveal groups of proteins that group
together with high confidence, thus are likely to be truly co-
localising (Fig. 1A). We used three diﬀerent bootstrapping
stringency cut-oﬀs of p-value o0.05, 0.01, or 0.001, revealing
365, 271, or 101 bootstrapped clusters (Dataset S3, ESI†), which
correspond to 4415, 3087, or 1487 pair-wise co-localisations,
respectively (Dataset S4, ESI†). While over 50% of identified
bootstrapped clusters contain only 2 or 3 proteins, clusters of
10 or more proteins were also detected (Fig. 1L), suggesting that
COLA can detect both small and large complexes.
Table 1 Top GOCC category enrichments in each COLA fractions. Selected highly enriched terms from (Dataset S2, ESI) are listed
Fraction Significantly enriched GOCC terms (FDR o 0.02)
1 Cytosol; intracellular
2 Membrane part; integral component of plasma-membrane; organelle membrane
3 Nuclear part; nucleoplasm part; transcription factor complex; chromatin remodelling complex; chromatin
4 Nuclear part; protein–DNA complex; nucleosome; chromosome; nuclear chromosome part; nuclear body
5 Intermediate filament; nuclear membrane; nucleolus
6 Intermediate filament; nuclear membrane; nucleolus
7 Protein–DNA complex; chromatin remodelling complex; nucleoid; organelle part; membrane part
8 Organelle membrane; membrane enclosed lumen; respiratory chain complex
9 Plasma membrane; cell junction; coated pit; endosome membrane; membrane part; protein–DNA complex
10 Cytosolic small ribosomal subunit; cytosolic large ribosomal subunit; proteosome complex; MCM complex
11 Actin cytoskeleton; ruﬄe; cell projection; cell junction; adherens junction; synapse; plasma membrane
12 Extracellular space; extracellular matrix; basement membrane; secretory granule lumen
actin (ACT) and vimentin (VIM), cytoskeletal proteins; L =matching whole cell lysate control. (D) Validation of serial centrifugation method (fractions 7–10)
by western blotting: N-cadherin (CHD2) and ezrin/radixin/moesin proteins (ERM), plasma membrane; early endosomal antigen-1 (EEA1), endosomal; PDI,
ER membrane protein; H2AX, nucleosome constituent; L = matching whole cell lysate control. (E) Validation of protrusion purification method (fraction 11)
by western blotting: VASP, protrusion; H2AX, nuclear; L = matching cell-body lysate control. (F) Validation of conditioned media collection method
(fraction 12) by western blotting: fibronectin-1 (FN1), secreted; GAPDH, intracellular; L = matching whole cell lysate control. (G) Heat map of Pearson
correlation coefficients between the two SILAC replicate series of fractionations with switched labelling. Cells were fractionated in duplicate with
switching the labels. Collected fraction mixes have high similarity with their corresponding replicate, but low similarity with other fractions. (H) Plotted
averaged Pearson’s correlation coefficients within replicate fractions versus averaged Pearson’s correlation coefficients between different fractions.
While a high degree of similarity exists within replicate fractions suggestive of high reproducibility, similarity between different fractions is very low,
indicating that each fraction is likely providing unique information. (I) Distribution of SILAC ratios for each fraction (averaged from two replicates). Red
lines mark the standard deviations for each fraction. (J) Principle component analysis of subcellular fractions. PC1 and 2 represent over 50% of all data
variation. No single fraction contributes towards the overall variation disproportionately. (K) Analysis of the reproducibility of the overall fractionation
signatures between two biological replicates. Euclidean distances between each protein signatures from two reciprocally SILAC labelled COLA
fractionations were calculated and plotted against each other, showing a highly significant correlation (p o 1.0  1015). The Pearson correlation
coefficient (CC) is displayed on the graph. (L) Graph of percentage of total bootstrapped clusters (p o 0.05) vs. the number of proteins per cluster.
The majority of clusters are constituted of 2–4 proteins, yet very large clusters are still detectable by COLA.
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To verify that COLA predicts real interactions, we assessed
its performance in detecting known interactions using three
major mammalian functional interaction databases as reference:
(1) CORUM, a highly curated database of mammalian protein
complexes,25 (2) STRING, a larger database of both physical and
functional associations.23 (3) Pathway Commons, a comprehen-
sive collection of functional and physical interactions integrated
from multiple publicly available databases.24 We quantified the
proportion of co-localising proteins in our method that appear
as known functional interactors in each database (Dataset S4,
ESI†). Over than half of the COLA identified interactions are
annotated as known interactions based on the Pathway Com-
mons database – the largest collection of functional protein
interactions (Fig. 2A). Moreover, around 1 in five of COLA inter-
actions are annotated as known in STRING database (Fig. 2B),
and a similar percentage of overlap with CORUM interaction
database was also detected (Fig. 2C). All of these degrees of
overlap are statistically highly significant (p-valueo1 10300).
For comparison, we also evaluated the performance of two
published large-scale studies which used different approaches
to map human protein–protein interactions as a proxy for
functional associations: (1) Rolland et al., which used Y2H
screening,6 and (2) Kristensen et al., which used size-exclusion
chromatography coupled with proteomics (SEC-MS).12 Although
both studies significantly detected known interactions, they
were both consistently outperformed by COLA in every database
comparison (Fig. 2A–C). Interestingly, the overlap between each
of these three approaches was little despite the significant
degree of overlap with the reference databases, suggesting that
each method must be revealing complementary information
with regards to functional associations (Fig. 2D). These results
demonstrate that significant similarity in protein localisation
signatures is strongly reflective of a functional interaction, and
that COLA outperforms Y2H and SEC-MS methods in revealing
functional interactions.
Analysis of interactome dynamics by iCOLA
Next, we optimised COLA for analysis of interactome dynamics.
A key factor for revealing the dynamics of protein interaction
networks is the ability to reliably multiply interactome analyses
across several conditions. Thus, high reproducibility along with
short analysis times are two crucial criteria for any method
designed for analysis of interactome dynamics. The SILAC based
COLA method requires a single mass spectrometry run for every
fraction/lysate SILAC mix. This equates to a total of 24 runs
(2 12 reciprocally labelled fraction/lysatemixes) for every analysis,
Fig. 2 COLA reveals known functional associations and outperforms two current global interactome analysis studies. (A) Percentage of overlap with
Pathway Commons between the identified interactions in each bootstrap significance setting, vs. in Kristensen et al.,12 vs. in Rolland et al.,6 P***: fisher’s
exact test po 1  10300; **: fisher’s exact test po 2  10150; *: fisher’s exact test po 1  1075. (B) As in (A) but for overlap with STRING (darker blue
indicates physical interactions only). (C) As in (A) but for overlap with CORUM. (D) Venn diagram of the overlap between binary protein–protein
interactions revealed COLA versus Kristensen et al., size-exclusion chromatography profiling12 and Rolland et al., Y2H screening.6 Only 2 interactions are
shared across the three methods.
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Fig. 3 Analysis of interactome dynamics by iCOLA. (A) Outline of the iCOLA methodology. 9 fractions from serial solubilisation and serial centrifugation
protocols, along with a 2% SDS solubilised whole cell lysate total control, were digested and isobarically labelled using TMT 10-plex kit as indicated. The
labelled peptides were then pooled together and analysed by LC-MS3. Averaged normalised fraction/lysate ratios for every fraction were used to create a
multi-variate subcellular localisation signature for each protein (T-complex protein 1 subunit alpha was used as example here). Signatures were then
subjected to unsupervised hierarchical clustering with Euclidean average linkage and bootstrapping was used to reveal clustering matches with high
confidence (in color) from the rest (blacked out). All members of the TCP1 chaperonin ring complex (CCT1 to 8) are detected as significant interactors of
CCT1, and are shown as an example of a bootstrapped cluster. (B) Graph of percentage of total bootstrapped clusters (p o 0.05) vs. the number of
proteins per cluster from iCOLA analysis of A375P cells. The majority of clusters are constituted of 2–4 proteins, yet very large clusters are still detectable
by iCOLA. (C) Heat map of Pearson correlation coefficients between the two replicate iCOLA series of fractionations. Cells were fractionated in duplicate.
Collected fractions show high similarity with their corresponding replicate, but low similarity with other fractions. (D) Plotted averaged Pearson’s
correlation coefficients within replicate fractions versus averaged Pearson’s correlation coefficients between different fractions. While a high degree of
similarity exists within replicate iCOLA fractions suggestive of high reproducibility, similarity between different fractions is very low, indicating that each
fraction is likely providing unique information. (E) Analysis of the reproducibility of the overall localisation signatures between two biological replicate
iCOLA experiments. Euclidean distances between the signatures from two independent iCOLA fractionations experiments in A375P cells were calculated
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which translates into a total mass spectrometry run time of
around 5 days, using our LC-MS/MS settings. To reduce the
number of mass spectrometry runs required in order to allow
rapid analysis of interactomes across multiple conditions, we
developed a modified version of our method (iCOLA), utilising
Tandem Mass Tagging (TMT) isobaric labelling which allows
mixing and quantification of up to 10 diﬀerent samples in a
single mass spectrometry run.29 To have all the fractions analysed
in a single TMT run, we modified our fractionation procedure to
have a total of 9 fractions plus 1 whole cell lysate (Fig. 3A). We
focused on serial solubilisation and serial centrifugation proce-
dures which provide the bulk of subcellular coverage, and also
mixed the two cytoskeletal fractions from serial solubilisation
protocol, which had the highest degree of similarity (Fig. 1J), into
one fraction (Fig. 3A). Co-localisations were identified as before
by determining significant similarities between subcellular loca-
lisation signatures using bootstrapped clustering (Fig. 3A). We
applied iCOLA to analyse co-localisations in A375P melanoma
cells.30 Overall, we identified 2276 proteins, complete sub-
cellular localisation profiles of 1846 of which were defined
across all fractions in A375P cells (Dataset S5, ESI†). At the
bootstrap cut-oﬀ of p-value o0.05, a total of 357 bootstrap
clusters were revealed (Dataset S6, ESI†), corresponding to 4916
pair-wise co-localisations (Dataset S7, ESI†). Similar to the
SILAC based COLA, the majority of iCOLA identified boot-
strapped clusters contained only 2 or 3 proteins, but clusters
of 10 or more proteins were also detected (Fig. 3B), suggesting
that iCOLA performs comparably to the SILAC based COLA in
detecting both small and large complexes. To assess iCOLA’s
reproducibility, we determined Pearson’s correlation coeﬃcients
across all fraction replicates as before. Correlation coeﬃcient
within fraction replicates was on average 0.92, which is better
than COLA, while coeﬃcients between diﬀerent fractions was on
average 0.08 (Fig. 3C and D). In addition, the correlation between
the overall fractionation signatures across two independent
biological replicates was calculated to be 0.85 (Fig. 3E), which
is also better than that of COLA. The improved reproducibility
of iCOLA is likely due to the fact that protein quantifications
are derived from the same peptides in every fraction, as every
identified TMT labelled peptide returns a quantification value
for each fraction. In contrast, the same protein can be quantified
through diﬀerent SILAC labelled peptides in each fraction/lysate
mix of COLA, thus increasing the likelihood of noise.
Next, we applied iCOLA to reveal interactome diﬀerences
between our previously analysed A375P cells, which are weakly
metastatic, to their highly metastatic isogenic derivative, the
A375M2 cells.30 We identified 1442 proteins with complete
subcellular localisation profiles in A375M2 cells (Dataset S8,
ESI†). At the bootstrap cut-oﬀ of p-value o0.05, a total of 279
bootstrap clusters were revealed for A375M2 cells, (Dataset S9,
ESI†), corresponding to 4779 pair-wise co-localisations (Dataset S10,
ESI†). First, to test whether the performance of iCOLA is similar
to COLA in terms of identifying true functional interactions
in both cell-types, we assessed the overlap of the identified
co-localisations with CORUM, STRING, and Pathway Commons
interaction databases, as before (Datasets S7 and S10, ESI†).
A highly significant proportion of the revealed co-localisations
were amongst known functional interactors in both A375P and
A375M2 cells (Fig. 3F–H), with the degree of overlap being com-
parable to that of the SILAC based COLA method, suggesting
that reducing the number of fractions from 12 to 9 does not
significantly affected the ability of our approach to reveal true
interactions. Next, we assessed the degree of overlap between
the interactomes of the two cell-lines. 1269 of the interactions
identified in total were seen in both A375P and A375M2 cells,
whilst more than 3000 interactions were detected in only one
cell-type (Fig. 3I). Category enrichment analysis revealed that
most conserved interactions belonged to core cellular complexes
such as the nucleosome, chaperonin complex, and the ribosome,
suggesting that these core interactions do not change much
across the two cell-types (Dataset S11, ESI†). In contrast,
mitochondrial protein complexes were significantly enriched
amongst proteins with changing interactions (Table 2 and
Dataset S11, ESI†), suggestive of a substantial rewiring of the
mitochondrial interactome between the two cell types. As a
result, we hypothesized that mitochondrial activity is likely to
be significantly altered between the two cell types. Accordingly,
both basal and spare mitochondrial respiratory capacity was
significantly reduced in A375M2 cells compared to A375P
cells (Fig. 3J). Collectively, these results demonstrate that
iCOLA can be used for comparison of functional interactomes
between different conditions, and that variations between
and plotted against each other, showing a highly significant correlation (p o 1.0  1015). The Pearson correlation coeﬃcient (CC) is displayed on the
graph. (F) Comparison of the percentage of known interactions according to Pathway Commons that were detected in A375P and A375M2 cells
(po 0.05). Percentage of overlap with Pathway Commons was very similar in A375P and A375M2 cells, and comparable to SILAC based COLA (Fig. 2A).
***: fisher’s exact test p o 1  10300; **: fisher’s exact test p o 2  10200. (G) Comparison of the percentage of known interactions according to
STRING that were detected in A375P and A375M2 cells (p o 0.05). Light blue bars shows all STRING interactions. Dark blue bars show only physical
interactions. Percentage of overlap with STRING was very similar in A375P and A375M2 cells, and comparable to SILAC based COLA (Fig. 2B). ***: fisher’s
exact test po 1  10300; **: fisher’s exact test po 2 10200. (H) Comparison of the percentage of known interactions according to CORUM that were
detected in A375P and A375M2 cells (p o 0.05). Percentage of overlap with CORUM was very similar in A375P and A375M2 cells, and comparable to
SILAC based COLA (Fig. 2C). ***: fisher’s exact test po 1  10300; **: fisher’s exact test po 2  10200. (I) Venn diagram of the overlap between binary
protein–protein interactions detected in A375P and A375M2 cells (bootstrap cut off = 0.05). A core of 1269 interactions were conserved between the two
isogenic cell lines, while over 3000 unique interactions were detected in each cell-line. (J) Analysis of mitochondrial respiratory flux in A375P and A375M2
cells. Oxygen consumption (OCR) was measured in real-time, with serial addition of oligomycin to inhibit ATP synthase, FCCP to uncouple oxygen
consumption from ATP production, and rotenone/antimycin (R/A) to completely inhibit electron transport chain, at indicated timepoints. Values were
normalised to total seeded cell numbers. A375P show a significantly higher basal mitochondrial respiration (blue arrow), as well as a higher maximal
mitochondrial respiratory capacity (red arrow), while levels of non-mitochondrial oxygen consumption measured after R/A addition (three ending time points)
are equal between both cells.
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interactomes can inform on functional differences between
different cellular settings.
COLA is sensitive and specific
We next assessed the quality of COLA and iCOLA for inter-
actome mapping, by calculating four critical parameters that
measure key attributes of a given global protein–protein inter-
action detection method, as outlined by Vidal and colleagues.27
These four parameters are completeness, False Positive Rate
(FPR), Sensitivity (Recall), and Precision. Completeness is the
measure of the percentage of total possible interactions covered
by an assay. FPR is the probability of reporting a false inter-
action. Sensitivity is the measure of the percentage of all true
interactions that are reported by the assay. Finally, Precision
measures the percentage of reported interactions which are
true. Assay completeness directly corresponds to the number of
investigated proteins (i.e. in our case proteins which were
identified and quantified in all fractions). Assuming that there
are B22 500 proteins in human genome, the total size of the
possible interactome is equal to 22 500  22 500/2 = 253125 000.
In COLA, we identified 1886 proteins, meaning that 1886 
1886/2 = 1 778 498 possible interactions were tested, which is
B1.4% of the total possible interactome space. This compares
similarly with Kristensen et al., SEC-MS method for mining of
interactions,12 but is less than most Y2H screens, which cover a
larger ORFome space.6,27
In a binary interactome analysis, assuming the null-hypothesis
(H0) equates to proteins A and B not interacting (false interaction),
and alternative hypothesis (H1) to A and B interacting (true
interaction), various types of possible interactions can be defined,
which are listed in (Table 3).
Assuming that the null hypothesis (H0) in a protein–protein
interaction detection assay is no interaction, and the alternative
hypothesis (H1) is existence of an interaction, a global binary
interactome analysis method can report two types of inter-
action: true positive (S), and false positive (V). The total number
of reported interactions (R) is therefore the sum of S and V.
Conversely, the unreported interactions consist of true (U) and
false negatives (T), with the total number of unreported inter-
actions (R0) consisted of the sum of U and T. In addition, all true
interactions in the interactome space (M), whether reported or
not by the method, can be defined as the sum of S and T.
Similarly, all false interactions in the interactome space (M0),
whether reported or not, can be defined as the sum of V and U.
Finally the total size of the hypothetical interactome space (A)
can be defined as the sums of M and M0, or R and R0.
Accordingly, FPR, Sensitivity, and Precision can be defined
as a function of these types of interactions:
 Sensitivity = S/M
 FPR = V/M0
 Precision = S/R
CORUM is a highly curated database of well-known protein
interactions, which can be regarded as almost ‘True’.25 To
estimate Sensitivity, we can therefore simply calculate the propor-
tion of CORUM interactions that were reported by COLA, for the
list of identified input proteins. COLA and iCOLA have a Sensitivity
ofB3% to 6%, depending on the bootstrapping cut-oﬀ (Fig. 4A).
In comparison, based on CORUM, Kristensen et al.’s SEC-MS
method12 and Rolland et al.’s Y2H study6 had Sensitivities
ofB8% andB2%, respectively (Fig. 4A). Thus, COLA is roughly
similar in terms of its Sensitivity to both of these existing
methods.
Estimation of FPR is somewhat tricky as no reference
database of false interactions (protein–protein interactions that
definitely do not occur) exists. To circumvent this problem, we
used two alternative approaches to generate lists of likely to be
false interactions. In the first approach, we simply made a list
of 200 randomly generated interactions which were not reported
to interact with one another in any known protein interaction
database (thus at least enriched in false interactions compared to
the background), and calculated the percentage of these inter-
actions that were detected by COLA and iCOLA. This method has
been utilised by Vidal and colleagues to estimate the FPR of
various Y2H screens, which were reported at 0.5 to 2%.27 The
downside of such an approach is potential errors that could be
introduced due to random sampling. To counteract such bias,
Table 3 Definition of the type of interactions in a given interactome analysis experiment
H(0) is correct H(1) is correct Sum
Reported interactions V (false positives) S (true positives) R
Unreported interactions U (true negatives) T (false negatives) R0
Sum M0 (total false interactions) M (total interactions) A
Note: V + S = R; U + T = R0; V + U = M0; S + T = M; M0 + M = A.
Table 2 Top rewired protein categories between A375P and A375M2
interactomes (from Dataset S11, ESI)
Category
database Category name
Corum 55S ribosome, mitochondrial
Keywords Ligase
GSEA RESPIRATORY_ELECTRON_TRANSPORT
GOBP Coenzyme metabolic process
GOBP Cofactor metabolic process
GOCC Mitochondrial matrix
Keywords Mitochondrion
Keywords Transitpeptide
GOCC Mitochondrial part
GSEA TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT
GSEA WONG_MITOCHONDRIA_GENE_MODULE
GSEA MOOTHA_MITOCHONDRIA
GOBP Oxidation–reduction process
GSEA MOOTHA_HUMAN_MITODB_6_2002
GSEA MITOCHONDRION
GOCC Mitochondrion
GSEA LEE_BMP2_TARGETS_DN
GOBP Small molecule metabolic process
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we repeated our sampling of the 200 unreported interactions
a thousand times, calculating the FPR for all of them and
averaging the resulting values. Based on this approach, COLA
and iCOLA were estimated to have FPR of 0.02 to B0.1%
depending on the bootstrapping cut-off (Fig. 4B). Using the
same estimation strategy, FPR of Kristensen et al.’s SEC-MS was
calculated to beB0.03% while Rolland et al.’s Y2H had an FPR
of B0.1% (Fig. 4B).
A major issue with the aforementioned strategy is that many
unreported interactions maybe yet undiscovered true interac-
tions as opposed to false ones, and this is particularly likely if a
given protein is not well studied in terms of its interactions,
thus not well annotated in interaction databases. So as an alter-
native approach to generate a library of likely to be false inter-
actions, we used a method based on a strategy recently proposed
by Foster and colleagues.31 In this method, it is reasoned that as
CORUM is a highly curated database of well-known protein
interactions, if a given protein is already annotated in CORUM,
it is likely that its interactions are better defined, so if two such
CORUM annotated proteins are not reported to interact with
each other, they are more likely to be false interactors. Based on
this rationale, we created a library of possible false interactions,
which we named anti-CORUM (proteins which are listed in
CORUM but not known to interact), and used it to estimate the
FPR by calculating the percentage of these anti-CORUM inter-
actions that were identified by COLA and iCOLA. Depending
on the bootstrapping cut-oﬀ stringency, COLA and iCOLA’s
FPR was estimated at 0.02 toB0.19% (Fig. 4C). Using the same
strategy, the FPR for Kristensen et al.’s SEC-MS was B0.25%
while Rolland et al.’s Y2H had an FPR of B0.14% (Fig. 4C).
Thus, the FPR of COLA and iCOLA are better than that of
SEC-MS, and better or comparable with Y2H, depending on the
bootstrapping cut-oﬀ.
Finally, using the anti-CORUM estimated Sensitivity and
FPR, we estimated V, S, U, and T values (Table 3), which allowed
calculation of Precision for COLA and iCOLA. Depending on the
bootstrapping cut oﬀ stringency, COLA and iCOLA’s Precision
were calculated at B61 to 79%. In comparison, SEC-MS had a
Fig. 4 Analysis of Sensitivity, FPR, and Precision for COLA and iCOLA. (A) Comparison of Sensitivity, also termed Recall, between COLA (at bootstrapping
cut oﬀ p-values of 0.05, 0.01, and 0.001), iCOLA (at cut oﬀ p-value of 0.05), Kristensen et al.’s SEC-MS method,12 and Rolland et al.’s Y2H screen.6
Sensitivity was defined as percentage of interactions present in CORUM that were identified by each method. (B) Comparison of FPR between COLA
(at bootstrapping cut oﬀ p-values of 0.05, 0.01, and 0.001), iCOLA (at cut oﬀ p-value of 0.05), Kristensen et al.’s SEC-MS method,12 and Rolland et al.’s
Y2H screen.6 FPR was defined as the percentage of interactions from a list of randomly selected 200 binary interactions not previously reported in any
database (see Materials and methods) which were identified by each method. The sampling of 200 unknown interactions was performed 1000 times, and
percentage values were averaged and displayed. (C) An alternative comparison of FPR, between COLA (at bootstrapping cut oﬀ p-values of 0.05, 0.01,
and 0.001), iCOLA (at cut oﬀ p-value of 0.05), Kristensen et al.’s SEC-MS method,12 and Rolland et al.’s Y2H screen.6 FPR was defined as percentage of
interactions present in the anti-CORUM dataset (see Materials and methods) that were identified by each method. (D) Comparison of Precision between
COLA (at bootstrapping cut oﬀ p-values of 0.05, 0.01, and 0.001), iCOLA (at cut oﬀ p-value of 0.05), Kristensen et al.’s SEC-MS method,12 and Rolland
et al.’s Y2H screen.6 As the total size of the hypothetical interactome space (A), as well as the total number of reported (R) and unreported (R0) interactions
are known for each method, the measures of Sensitivity (S/M) and FPR (V/M0) can be used to estimate S, M, M0, T, and U values. Precision was then
calculated as S/R, and displayed as a percentage value. COLA, and iCOLA have comparable or slightly better Precision than Kristensen et al.’s SEC-MS
method, but both vastly outperform Rolland et al.’s Y2H.
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Precision of B65%, while Y2H Precision was B10% (Fig. 4D).
Thus, while COLA and iCOLA have comparable or slightly better
Precision than Kristensen et al.’s SEC-MS, they vastly out-
perform Rolland et al.’s Y2H screen. Collectively, these results
demonstrate that significant similarity in protein localisation
signatures can be confidently used to reveal interactions, and
that COLA and iCOLA vastly outperform Y2H in terms of
Precision, which is the key measure of assay specificity.
Discussion
Robust methods that reveal dynamics of functional interactions
between proteins on a global scale are crucial for system level
understanding of cellular processes. Quantitative proteomics in
conjugation with biochemical fractionation by chromato-
graphy,11–13 is a recent approach that attempts to address the
issue of assessing interactome dynamics, but is limited to soluble
proteins and can miss on more transient interactions. Here, we
present COLA, a global proteomics based strategy that reveals
significant co-localisation as a proxy for functional associations.
Our approach is not limited to soluble protein complexes and
does not solely report biochemical associations. Instead, it
robustly matches interacting proteins based on similarity in their
multi-dimensional subcellular localisation signatures. In addi-
tion, COLA requires significantly less number of proteomics runs
per experiment than the previously published chromatography
based methods.11,12 All subcellular fractionations can be per-
formed in a single day, with proteomics sample preparation and
digestion taking two additional days. If the iCOLA approach is
used, mass spectrometry runs will only take a few hours, meaning
that the whole analysis can be completed in less than a week,
including data processing and clustering. This makes iCOLA
much faster than any previously published global protein–protein
interaction analysis method, and ideal for studying global inter-
actome dynamics. As a proof of principle, we here used iCOLA for
such analysis, comparing the interactomes of weakly and highly
metastatic isogenic melanoma cells. Our analysis revealed a
significant rewiring of the mitochondrial interactome (Table 2),
and in line with this observation, the mitochondrial respiratory
activity was found to be significantly altered between the two
cell-lines (Fig. 3J). The functional significance of this metabolic
change with regards to the metastatic potential of the cells
remains to be determined.
Although subcellular localisation of proteins has been studied
by proteomics before,28,32–37 the focus of most of these studies has
been on assigning proteins to different organelles rather than
revealing protein–protein interactions. Comprehensive subcellular
localisation profiling to reveal interactions has been performed
by microscopy, using high-throughput fluorescent tagging in
combination with high-content imaging.14 Also, a related non-
microscopy based method known as proximity based biotin
labelling functions by tagging bait proteins with a promiscuous
biotin ligase, which then biotinylates any closely localising
proteins in vivo, allowing their subsequent affinity purification
and identification of by mass spectrometry. However, similar to
Y2H or AP-MS, both these approaches suffer from the labour
intensive need to tag every target protein in a cell-type of interest,
and are prone to potential artefacts caused by the addition of a
fluorescent or a biotin ligase tag. In contrast, COLA can be applied
to any cell-type, and in a fraction of the time required for other
methods. Fractionations, sample preparations, and computa-
tional methods used in COLA are all well established, making it
a readily available tool to a wide range of biologist across diverse
fields. Finally, our benchmarking shows that COLA and iCOLA
compare favourably with some of the existing methods of inter-
actome mining in terms of the quality of their interactome data.
With regards to their Sensitivity, COLA and iCOLA are comparable
with SEC-MS, and perform better than Y2H (Fig. 4A). More
importantly, COLA and iCOLA perform comparable or better than
SEC-MS in terms of their Precision, while greatly outperforming
Y2H (Fig. 4D). COLA and iCOLA therefore compare favourably
with some of the existing global methods for reliable unbiased
mining of interactomes.
Conclusions
Subcellular localisation of a protein is an important determinant
of the functional interactions it can form in a given cellular
context. COLA uses a quantitative proteomics approach to assess
subcellular localisation of proteins on a global scale, and then
matches proteins with highly similar subcellular localisation
patterns using multi-variate localisation signatures. The rapid
nature of COLA, its applicability to almost any cell-type, as well
as its accuracy and ease of use for revealing functional inter-
actions on a global scale, renders it highly suitable for assessing
functional interactomes across multiple conditions and treat-
ments. We predict that such an approach is likely to have a
decisive impact on systems level analysis of functional inter-
actions, as methods to rapidly reveal interactome dynamics on
a global scale are desperately needed.
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